Pf Magazine December 2018 – How time flies

Prefer to read in print? Subscribe for free here If you would like to feature in the next issue of Pf Magazine, contact us here //e.issuu.com/embed.js

Pf Magazine November 2018 – Sales Excellence

//e.issuu.com/embed.js November's Articles:  November 2018

Pf Magazine September 2018 – Brand Planning

//e.issuu.com/embed.js This month's articles: September 2018

Pf Magazine August 2018

What's next for field sales? //e.issuu.com/embed.js

Pf Magazine July 2018

Market Access Special Edition //e.issuu.com/embed.js   Articles from this edition: July 2018

Pf Magazine June 2018

The NHS turns 70 //e.issuu.com/embed.js

Pf Awards May 2018

Post Awards Brochure //e.issuu.com/embed.js

Pf Magazine April 2018

The biggest Pf Awards yet //e.issuu.com/embed.js

Pf Magazine March 2018

Pharma millennials //e.issuu.com/embed.js

Latest articles

Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...
NICE recommend funding for Spinraza

NICE recommend funding for Spinraza for spinal muscular atrophy

The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service (NHS). The positive recommendation, subject to...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
Data from Symbicort Turbuhaler Novel START trial among 73 AstraZeneca abstracts accepted for presentation at ATS

New data from Novel START trial accepted for presentation

New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
Dr Harry Destecroix of Ziylo wins 2019 Pharmaceutical Industry Network Group Innovation Award

Biotech leader wins PING Innovation Award 2019

Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...